(HA) induces a jumping behavior in rats when the central dopaminergic function has been activated.
is a tremorgenic alkaloid and induces tremors in rats and mice (1) (2) (3) . We have demonstrated that administration of harmine in combination with apomorphine (APO) induced a violent jumping in rats instead of a tremor. This behavior was induced by HA when the central dopaminergic func tion was activated by treatment with APO or L-DOPA plus benserazide (4) , and the lump ing activity was correlated with the brain HA concentration (5) . HA is a potent monoamine oxidase (MAO) inhibitor (6) , and it was con sidered that the elevation of brain mono amines induced by HA would be related to this behavior. However, the fact that other MAO inhibitors did not produce this be havior (4) suggested another mode of action.
Kelly and Naylor (3) have reported that hyperactivity induced by HA and dopamine agonists such as APO and methamphetamine was abolished following lesioning of the globus pallidus. From this area, the pallido nigral pathways arise and terminate in the substantia nigra in which these pathways are connected with the nigrostriatal dopaminergic pathways.
r-Aminobutyric acid (GABA) is the most likely candidate for the neurotrans mitter utilized in the pallidonigral pathways (7) . Jones et al. (8) have demonstrated that microinjection of picrotoxin, a GABAergic antagonist, into the nucleus accumbens pro duced running behavior similar to the jumping behavior induced by HA and APO. Also, microinjection of picrotoxin into the superior colliculus caused an explosive running behavior which was potentiated by the pre treatment with APO (9, 10). These results indicated that inhibition of the GABAergic function by picrotoxin was responsible for induction of these behaviors and that the GABAergic function was closely related to the dopaminergic function.
Several 8-carbolines have high affinity for the benzodiazepine receptors (BZA-R) (11), and ethyl -l3-carboline carboxylate (i3-CCE), has been referred to as an inverse agonist of BZA-R (12). Among several (3-carboline com pounds, methyl -(3-carboline-3-carboxylate (13-CCM) and harmane induced convulsion (13, 14) and norharman and harmaline in duced a tremor (15-17).
These abnormal behaviors were antagonized by diazepam or Ro 15-1788 treatment, and it has been sug gested that inhibition of the BZA-R by these ,3-carbolines was partly responsible for the induction of the tremors or convulsions.
The BZA-R is associated with the GABA Cl ionophore-receptor complex (18); and in recent years, the receptor complex has been purified from several species as an oligomer with two major polypeptide bands (19). In addition, it has been established that diaze pam facilitates the GABAergic function via interacting with BZA-R (20).
The purpose of the present study is to reveal whether or not the GABAergic systems and BZA-R would be involved in the jumping behavior induced by HA and APO in rats. We have investigated (1) the effect of GABAergic agonists and antagonists on the jumping be havior induced by HA and APO and (2) the effect of HA on the BZA-R and GABA receptor (GABA-R) in vitro and in vivo. Relationships among the intensity of the jumping behavior, change of 3H-diazepam binding to the BZA-R and brain HA concen trations were also determined in rats after treatment with HA and APO. Ci/mmol) and 3H-muscimol (15.4 Ci/mmol) were obtained from New England Nuclear (Boston, U.S.A.). All other chemicals used were of analytical grade.
Materials and Methods

Drugs
Drug treatment: Male Wistar rats (Japan Rat Co., Urawa, Japan) weighing 120±20 g were housed in an air conditioned room with a 12 hr light-dark cycle and given a commer cial diet and water ad libitum. HA, APO and muscimol were dissolved in distilled water; and bicuculline and picrotoxin were dissolved in weak acid by heating. Diazepam was dis solved in a small amount of ethanol and diluted by 0.9% NaCI solution. Muscimol, bicuculline, picrotoxin and diazepam were given s.c. 30 min before HA and APO treat ments. AOAA (an inhibitor of GABA trans aminase (21)) and semicarbazid (an inhibitor of glutamic acid decarboxylase (22)) were dissolved in distilled water and given s.c. 6 hr and 1 hr before HA and APO, respectively. Ro 15-1788, a selective BZA-R antagonist (23), was suspended in 0.4% carboxylmethyl cellulose and given i.p. 30 min before HA and APO. 3-Acetylpyridine, which degenerates the climbing fiber projection from the olivary nucleus to the Purkinje cells of the cerebellum (24), was diluted with 0.9% NaCl solution and given i.p. to rats 8 hr before HA and APO. 6 Hydroxydopamine was dissolved in 0.9% NaCI (0.1% ascorbic acid) solution and in jected into the lateral ventricles of rat brain to degenerate the dopaminergic fibers (250 ag/ day/rat for 2 days). One week later, HA and APO were given to the rats. The control rats were given the vehicle.
Measurement of jumping activity: The jumping behavior was assessed according to the method described in the previous paper (4). Groups of 5 rats were placed in the ob servation cage (41 x 25 x 1 5 cm) at least 30 min before administration of drugs to allow for adaptation to the new environment. The jumping behavior was recorded for 90 min after treatment with HA and APO. Fine vibra tion of the cage induced by the jumping movements of the rats was detected by a Minor Tremor Pick-up (MT-3, Nihon Kohden Kogyo, Co., Tokyo, Japan) attached under the center of the cage. The vibrations were amplified and continuously recorded using an inkwriting oscilloscope.
The recorded data were scored for quantitative and objective analysis by a scoring system (0, 1, 2, 3 and 4). The data were scored at 2 min intervals and averaged every 10 min. The well-lighted-room was maintained at a temperature of 20±2°C during the experiments, and observation was started at 1.00 p.m.
Brain membrane preparation: Ten min after administration of HA and APO, rats were de capitated. The brain was removed quickly and dissected into the following 7 regions: cerebral cortex (CTX), frontal cortex (FTX), corpus striatum (CS), cerebellum (CEL), hip pocampus (HIP), midbrain (MB) and pons medulla oblongata (P0). Crude membranes were prepared according to the method of Kuriyama et al. (25) with a minor modifica tion. Briefly, the brain tissues were homo genated in 20 volumes of 50 mM Tris-citrate buffer (pH 7.0) and centrifuged at 20,000xg for 30 min. The resulting pellets were frozen at least 24 hr at -40'C. After thawing, the pel lets were homogenized in 20 volumes of distilled water and centrifuged. The resulting pellets were homogenized in 50 mM Tris citrate buffer, centrifuged and resuspended in the original volume of 50 mM Tris-citrate buffer (pH 7.0).
Binding assay: 3H-Diazepam binding to BZA-R and 3H-muscimol binding to GABA-R were measured by the method of Ticku (26) and Kuriyama et al. (25), respectively. Mem brane suspension (50 or 100 id: equivalent to 2.5 or 5 mg tissue wet weight) was incubated for 30 min at 0°C with 1 nM 3H-diazepam or 3H-muscimol in 50 mM Tris-citrate buffer , pH 7.0 (final volume of 0.5 ml). The reaction was terminated by rapid filtration through What man GF/B filters, and the filters were im mediately washed with 3x3 ml ice-cold buffer. The radioactivity on the filters was counted in a liquid scintillation counter. Specific binding was determined as the dif ferences between total binding and binding in the presence of 1 /iM cold diazepam (for 3H-diazepam binding) or 2 mM GABA (for 3H-muscimol binding) . In the displacement experiments, displacers were added to the assay medium 5 min before 3H-diazepam or 3H-muscimol . IC50 values, the concentration of the displacers which inhibit specific 3H diazepam and 3H-muscimol binding by 50%, were calculated by log-probit analysis, using four to five different concentrations of the displacer. HA was dissolved in 50 mM Tris citrate buffer, and diazepam and i-CCE were dissolved in a small amount of ethanol and then diluted in 50 mM Tris-citrate buffer to an appropriate concentration. For Scatchard plots, the membranes (150 iig protein) were incubated with a wide range of 3H-diazepam (0.2-10 nM) in the presence and absence of 10-4 M HA. The Kd and Bma,,t values were ob tained by the linear regression of the Scat chard data. Protein concentration was esti mated by the method of Lowry et al. (27) .
Determination of HA concentration: The concentration was determined as described in the previous paper (5) . A part of the same membrane suspension as that used for the binding assay was added into the same volume of 0.2 N HCIO4 (50% methanol) solution to extract the HA. The mixtures were shaked well, centrifuged, and the filtrated supernatants were analyzed by high perfor mance liquid chromatography, employing a fluorometric detector. The excitation and em mision wavelengths were 320 nm and 420 nm, respectively. The mobile phase was a mixture of methanol and 0.2% phosphoric acid (60:40) at a flow rate of 1.0 ml/min. Data in the tables are expressed as the mean+S.E., and statistical significance was evaluated by Student's t-test. Behavioral scores were analyzed by the Mann-Whitney U-test.
Results
Modification
of jumping behavior by GABAergic agents: Figure 1 shows the effect of various agents modifying the GABAergic systems on the jumping behavior induced by 10 mg/kg of HA and 2 mg/kg of APO. Con trol (-O-) in the figure represents the score of rats treated with HA and APO. Rats began to run forward and subsequently jump with vocalization a few minutes after treat ment with HA and APO. The jumping be havior reached maximum 10 min later and gradually decreased, and rats recovers 90 min later. The pretreatment with muscimol slightly suppressed the jumping behavior at a dose of 0.05 mg/kg and almost completely sup pressed the jumping behavior at a dose of 0.1 mg/kg. At a dose of 0.2 mg/kg no excitation was found and rats appeared sedated (Fig.  I IA) . Pretreatment with diazepam at 0.5 and 1.0 mg/kg significantly decreased the in tensity and duration exhibiting the jumping behavior ( Fig.  1 B) . Pretreatment with GABAergic antagonists, picrotoxin and bicuculline, also decreased the intensity of the jumping and shortend the duration of the jumping behavior in a dose-dependent manner at doses from 0.1 to 0.5 mg/kg (Fig.  1 C, D) . Muscimol, diazepam, picrotoxin and bicuculline themselves did not affect the be havior of rats in all the doses used.
AOAA completely suppressed the jumping behavior at a dose of 50 mg/kg as well as 0.2 mg/kg of muscimol. Pretreatment with semi carbazid moderately suppressed the jumping behavior at doses of 0.1 and 0.2 mg/kg: scores 10 min after treatment with HA and APO significantly lowered to 1.87±0.2 (N=5) and 1.6±0.24 (N=5), as compared to 3.48± 0.29 (N=4) in the non-pretreated rats. At doses from 0.5 to 150 mg/kg of semicarbazid, jumping was not induced. Muscimol, diazepam, picrotoxin and bicuculline were given 30 min before the injection of harmine and apomorphine.
Scores of the jumping behavior were estimated as described in Materials and Methods. Control (-0-) indicates the scores of rats treated with harmine and apomorphine (no pretreatment).
Significant differences from the control were evaluated by the Mann-Whitney U-test (*P<-0.05 and **P<0.01).
Effect of 3-acetylpyridine and 6-hydroxy dopamine on the jumping behavior: Eight hr after treatment with 78 mg/kg of 3-acetyl pyridine, rats treated with HA (10 mg/kg) alone did not show any tremor. However, rats treated with HA and APO exhibited the jump ing behavior with a long resting period from jump to jump. There was no difference in the brain HA levels between 3-acetylpyridine treated and vehicle-treated rats. On the con trary, treatment with 6-hydroxydopamine completely suppressed the jumping behavior induced by HA and APO (Table 1) .
Effect of HA on 3H-diazepam and 3H muscimol binding to the brain membranes in vitro: As shown in Fig. 2A , 10-4 M HA dis placed about 60% of the specific 3H-diazepam binding from the binding sites in CS and CTX membranes.
On the other hand, /3-CCE Table 1 . Effect of acetylpyridine and 6-hydroxydopamine on the jumping behavior and brain harmine concentrations in the corpus striatum showed a more potent effect on the BZA-R, which was comparable to that of diazepam: 10-9 M 9-CCE displaced 60% of the 3H diazepam binding. HA has a 100,000-fold less affinity to the BZA-R than (3-CCE. In the 3H-muscimol binding of the CS and CTX membranes, about 60% of the binding was displaced by 10-4 M HA, but 10-4 M (3-CCE had no effect on 3H-muscimol binding (Fig.  2B) (Table 2) , although in CEL membranes, it was more potent for 3H-diazepam binding and less potent for 3H-muscimol binding than in the other areas. The specific 3H-diazepam binding to the rat CS membranes was saturable in the presence and absence of 10-4 M HA (Fig.  3A) . From Scatchard plots, it was estimated that 3H-diazepam binds to the CS mem branes to a single site with an apparent Kd of 6.8±0.21 nM and Bmax of 599.5±99.7 fmole/ mg protein (Fig. 3B and Table 3 ). In the presence of HA, the apparent Ka value signifi cantly increased to 13.4±1.0 nM without change in Bmax. Similar effects of HA were observed in CTX and CEL membranes (Table  3) : HA lowered the affinity of 3H-diazepam to the BZA-R. From Line-weaver-Burk analysis of specific 3H-diazepam binding using data from the saturation experiment, HA was shown to compete with the 3H-diazepam at the binding site (data not shown). 3H-Diazepam and 3H-muscimol binding to the regional brain membranes in rats treated with HA and APO: Since the maximum jump ing behavior was observed 10 min after the treatment with HA and APO (Fig. 1) , 3H ligand binding was determined 10 min after treatment with HA and APO. Table 4 re presents specific 3H-diazepam binding to the regional brain membranes in rats treated with 2, 5 or 10 mg/kg of HA in combination with 2 mg/kg of APO. 3H-Diazepam binding to the membranes of the vehicle-treated control rats ranged from 2.43 (P0) to 9.94 (FTX) pmole/g tissue wet weight. High binding was observed in the FTX, HIP, CTX and MB. Changes in the 3H-diazepam binding were not found in the CTX, FTX, HIP, CEL, MB and PO membranes of rats treated with HA and APO even at a dose of 10 mg/kg of HA. In the CS, however, 3H-diazepam binding to the membranes after the same treatment tended to decrease in a dose-dependent manner; and at a dose of 10 mg/kg of HA, the binding significantly de creased to 67% of the control levels. Table 5 represents specific 3H-muscimol binding to the GABA-R in the regional brain membranes of rats treated with HA and APO. The binding to the membranes from the con trol rats indicated that there were regional differences:
high binding was found in the FTX and CEL, moderate binding in the HIP and CTX, and low binding was in the CS, M B and P0. There was no change in the 3H muscimol binding to the regional membranes of rats after treatment with HA and APO.
HA concentration in the regional brain pre parations: As shown in Table 6 , the regional HA concentrations after treatment with HA and APO increased with increasing doses of HA administered in all the regions: that is, HA concentrations ranged from 2.72 to 4.84 nmole/g at a dose of 2 mg/kg, 7.17 to 9.86 nmole/g at 5 mg/kg of HA and 13.76 to 20.25 nmole/g tissue wet in 10 mg/kg of HA treated rats. High HA concentrations were observed in the HIP at 2 mg/kg and M B at 2 and 10 mg/kg of HA. The CS showed high HA concentration at a dose of 10 mg/kg of HA. To Table 5 . Specific 3H-muscimol binding to the brain regional membranes of rats treated with harmine and apomorphine Table  6 . Harmine concentrations in the regional brain preparation of rats treated with harmine and apomorphine determine the relationship between brain HA levels and the jumping behavior, the correla tion coefficient between the regional HA con centrations and the jumping scores after treatment with 2, 5 and 10 mg/kg of HA was calculated (right column in Table 6 ). The scores at 10 min after HA and APO treatment were cited from the previous paper (5). The correlation coefficients (0.975-0.992) in dicated that the jumping behavior was closely correlated with the HA levels in the brain regions. In addition, the correlation coefficient between 3H-diazepam binding and HA con centrations was determined in all the regions. A negative correlation was found only in the CS membranes (r=0.999); the binding de creased with increasing HA concentration in CS. Table 7 . Effect of Ro 15-1788 on jumping behavior, harmine concentration and specific 3H-diazepam binding to the cortex and corpus striatum membranes In our study, decrease in 3H-diazepam binding to the BZA-R after treatment with HA and APO was observed only in the CS mem branes, in spite of the same potency of HA to the BZA-R in all the regions in vitro (Tables 2  and 3 ). The autoradiographic technique using 3H-flunitrazepam and selective displacers differentiated the central BZA-R to BZA, and BZA2 subtypes and visualized the distribution of the receptors (28). BZA2 was predominant in the CS and the superior colliculus, and BZA, was mainly located in the CTX, FTX, CEL and HIP. Therefore, the BZA-R in the CS and CTX or CEL may be affected by HA in dif ferent manners in vivo. Also, 3H-diazepam binding to the BZA-R indicated a different regional distribution (Table 4) as reported by Richards and Mdhler (12): distribution in the FTX, CTX and HIP was 2-3 times higher than that in the CS membranes. As there is no large difference of HA concentrations between CS and HIP, FTX or CTX (Table 6 ), real HA con centration per binding site might be higher in the CS than in the CTX or HIP. Decrease in 3H-diazepam binding to the CS membranes , however, is not likely due to a direct effect of HA remaining in the incubation medium, because the HA concentration in the binding assay medium was calculated to be 8 x10-8 M in rat CS treated with 10 mg/kg of HA, and the concentration did not affect 3H-diazepam binding to the CS membranes in vitro ( Fig.  2A) .
Treatment with APO may change the af finity of HA to the BZA-R in the CS, but we have no evidence to prove the possibility.
3H-Muscimol binding was not affected by the treatment with HA and APO in all the regions studied, even though HA displaced 3H-muscimol binding as well as 3H -diazepam from the binding site. It is likely that the GABA-R maybe less important than the BZA R in the jumping behavior. The results that both GABAergic agonists and antagonist suppressed the jumping be havior induced by HA and APO were unex pected, since agonists and antagonists were considered to have opposite effects on the GABAergic systems. That is, diazepam (BZA R agonist) and muscimol (GABA-R agonist) facilitate the GABAergic function via in teraction with the GABA-BZA-CI ionophore receptor complex (18). On the other hand, bicuculline (GABA-R antagonist) and picro toxin (CI ion channel blocker) inhibit the GABAergic transmission through interacting with the complex. It has been demonstrated in vitro that muscimol increased 3H-diazepam binding to CTX membranes, and bicuculline decreased the binding and blocked enhance ment of the 3H-diazepam binding by mus cimol (29). Braestrup and Nielsen (30) also reported that GABA and muscimol reduced binding of 3H-a-CCM to the brain BZA-R. In Fig. 4 , we showed that muscimol increased 3H-diazepam binding to the BZA-R and de creased the effect of HA to the BZA-R, and diazepam changed the effect of HA on 3H diazepam binding to the BZA-R. These results support that diazepam and muscimol would suppress the jumping behavior induced by HA and APO via interaction with the BZA GABA-receptor complex. As regards to the effect of picrotoxin and bicuculline, we could not demonstrate the interaction between HA and these two reagents in the BZA-R in vitro. However, it can not be excluded that picro toxin binds to the CI ionophore and bicucul line to the GABA-R, and consequently they would cause a conformational change of the complex to decrease the affinity of HA to the BZA-R, because picrotoxin caused a concen tration-dependent increase of 3H-flunitraze pam binding to rat CEL membranes in the presence of 150 mM NaCI (31). Handley and Singh (32) have reported that picrotoxin potentiated the head-twitching induced by 5-hydroxytryptophan as well as diazepam and muscimol. ,S-CCE inhibited the head twitch. They suggested that picrotoxin as well as muscimol affected the GABA-CI ionophore receptor complex and influenced the sero tonergic functions.
AOAA may recover the GABAergic function depressed by HA via elevating the brain GABA level. The effect of semicarbazid is not clear, because semicarbazide had an inhibitory effect on the jumping behavior at a small dose which dis not decrease the brain GABA levels (0.5 mg/kg) (22).
In the previous paper, we suggested that activation of the dopaminergic neurons was necessary induction of the jumping behavior by HA and APO (4) . The result that denerva tion of the dopaminergic neurons by 6 hydroxydopamine treatment abolished the jumping behavior induced by HA and APO confirmed this hypothesis.
3-Acetylpyridine failed to inhibit the jumping behavior, in dicating that the olivo-cerebellar systems do not play an important role in this behavior. The mechanism of the jumping behavior seems to be different from that of the tremor production by HA. Together with the finding that intrastriatal injection of GABAergic agonists affected the dopamine receptor via interaction with the GABA-R in the CS and inhibited the circling behavior induced by APO in rats (33), the present study suggests that modification of the BZA-R in the CS by HA may influence the dopaminergic and GABAergic pathways and consequently cause the induction of the jumping behavior.
